Nevakar Injectables (Six Development Stage -Injectable Product) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Nevakar Injectables (Six Development Stage -Injectable Product) General Information

Description

A portfolio of injectable products intended to resolve medication delays and compounding challenges.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 1019 US Highway, NJ Center of Excellence
  • Suite 202-206, Building K
  • Bridgewater, NJ 08807
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Drug Discovery
Acquirer
Endo International
Corporate Office
  • 1019 US Highway, NJ Center of Excellence
  • Suite 202-206, Building K
  • Bridgewater, NJ 08807
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nevakar Injectables (Six Development Stage -Injectable Product) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nevakar Injectables (Six Development Stage -Injectable Product)‘s full profile, request access.

Request a free trial

Nevakar Injectables (Six Development Stage -Injectable Product) Patents

  • 46

    Total Documents Applications and Grants

  • Total Patents Families

  • 26

    Granted

  • 8

    Pending

  • Expiring in next 12 mo

Nevakar Injectables (Six Development Stage -Injectable Product) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3235610-A1 Hydralazine compositions and methods Pending 29-Dec-2021
WO-2023130009-A1 Hydralazine compositions and methods Inactive 29-Dec-2021
CA-3209890-A1 Sodium bicarbonate injectable formulation and methods of use thereof Pending 26-Feb-2021
AU-2018244426-A1 Improved method of producing collagenase Active 28-Mar-2017
AU-2018244426-B2 Improved method of producing collagenase Active 28-Mar-2017 A61K31/00
To view Nevakar Injectables (Six Development Stage -Injectable Product)’s complete patent history, request access »

Nevakar Injectables (Six Development Stage -Injectable Product) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nevakar Injectables (Six Development Stage -Injectable Product)‘s full profile, request access.

Request a free trial

Nevakar Injectables (Six Development Stage -Injectable Product) FAQs

  • Where is Nevakar Injectables (Six Development Stage -Injectable Product) headquartered?

    Nevakar Injectables (Six Development Stage -Injectable Product) is headquartered in Bridgewater, NJ.

  • What industry is Nevakar Injectables (Six Development Stage -Injectable Product) in?

    Nevakar Injectables (Six Development Stage -Injectable Product)’s primary industry is Buildings and Property.

  • Is Nevakar Injectables (Six Development Stage -Injectable Product) a private or public company?

    Nevakar Injectables (Six Development Stage -Injectable Product) is a Private company.

  • What is the current valuation of Nevakar Injectables (Six Development Stage -Injectable Product)?

    The current valuation of Nevakar Injectables (Six Development Stage -Injectable Product) is .

  • What is Nevakar Injectables (Six Development Stage -Injectable Product)’s current revenue?

    The current revenue for Nevakar Injectables (Six Development Stage -Injectable Product) is .

  • Who are Nevakar Injectables (Six Development Stage -Injectable Product)’s investors?

    Nevakar Injectables has invested in Nevakar Injectables (Six Development Stage -Injectable Product).

  • When was Nevakar Injectables (Six Development Stage -Injectable Product) acquired?

    Nevakar Injectables (Six Development Stage -Injectable Product) was acquired on 09-May-2022.

  • Who acquired Nevakar Injectables (Six Development Stage -Injectable Product)?

    Nevakar Injectables (Six Development Stage -Injectable Product) was acquired by Endo International.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process